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ABBREVIATION  
1) HD   : Hirayama disease 
2) NCS  : Nerve conduction study 
3) CMAP  : Compound muscle action potential 
3) MN   : Median nerve 
4) UN   : Ulnar nerve 
5) MRI  : Magnetic resonance imaging 
6) BMA  : Benign monomelic atrophy 
7) C   : cervical  
8) T   : Thoracic 
9) CSF  : Cerebro spinal fluid 
10) Lt   : Left 
11) Rt  : Right 
12) Neck in E : Neck in extension 
13) Neck in F : Neck in flexion 
14) T1W /T2W : T 1 weighted or T2 weighted imaging on MRI 
15) M   : Male 
16) F   : Female 
17) f mean  : f mean latency 
18) SSEP  : Somato sensory evoked potential 
19) DTR  : Deep tendon reflex 
20) U/l  : Unilateral 
21) B/l  : Bilateral 
22) SNAP  :Sensory neural action potential 
  
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
  
 
 
INTRODUCTION 
Juvenile muscular atrophy of the unilateral upper limb localized to 
hand and forearm was first reported independently in 1959 from Tokyo by 
Keizo Hirayama et. al
(1)
 and Takagi, Okabe
(2)
. Benign monomelic 
amyotrophy (BMA) is considered a less common form of motor neuron 
disease of as yet unknown cause. In view of the first such case being 
reported by Keizo Hirayama, this disease is now being referred to as 
Hirayama disease.  
 
Focal muscular atrophy of unknown etiology has been reported 
since 1959 with different names as Juvenile muscular atrophy of unilateral 
upper extremity (Hirayama et al
(1)
., 1959: Singh et al
(3)
., 1980), Benign 
focal amyotrophy (Adornato et al
(4)
., 1978), Monomelic amyotrophy 
(Gourie-devi et al
(5)
., 1981), Sobue disease (Soube et al
(6)
., 1978). Wasted 
leg syndrome (Prabhakar et al
(7)
., 1981). Benign monomelic atrophy (Choi 
et al
(8,9)
., 1982: 1987: Cheong et al
(10)
., 1992). 
 
  
 
This disease was initially reported from Japan and later there has 
been numerous case series published predominately from Japan, India, 
Korea and China. There are numerous case reports published from Brazil, 
France, Germany, Italy, Spain, Turkey, Poland and Canada 
(11-15)
.  
 
Hirayama et.al  
(1,16,17)
  description of isolated upper limb atrophy   
was similar to "Tephromalacie Anterieur" reported  earlier by Marie and 
Foix
(20)
 in the year 1912.  This previous description was of localized hand 
muscle wasting which affected the middle aged people and elderly people 
predominantly, the pathogenic mechanism described for that entity  was 
different and had softening of the anterior horn in the lower cervical cord. 
Because of the similarity in clinical features a possible pathology of the 
lower cervical cord in juvenile muscular atrophy of distal upper extremity 
was thought of by keizo Hirayama and colleagues. 
 
Hirayama disease unlike motor neuron diseases is clinically non 
progressive after a period of time. Also histopathology of autopsied 
specimen was being interpreted to be suggestive of anterior horn cell 
  
 
ischemia in lower cervical spinal cord 
(1,13)
. Nerve conduction studies 
changes and MRI changes have also been described in literature.  
 
This study is undertaken to study  the Clinical features, Nerve 
conduction changes especially with reference to the ulnar and median f 
wave conduction in neck flexion and extension, MRI changes in neck 
extension and flexed position in patients with Hirayama disease attending  
govt. Stanley hospital Chennai.  
 
HIRAYAMA DISEASE 
  The clinical features of Hirayama disease were summarized based 
on previous studies 
(15-19)
. This disease affects people in their teenage or 
early second decade, it preferentially affects the males (male to female 
ratio = 20:1). There have been rare case reports of Familial occurrence, six 
pairs have been reported till date in over 300 case reports from Japan. 
 
  Description of patients presenting with similar complaints has 
been reported differently by authors. Each author had given a different 
  
 
name to describe the disease they were reporting as the etiology of this 
disease is largely unknown. This confusion in disease categorization led to 
the emergence of multiple synonyms for this spectrum of clinical 
syndromes.  
 
Patients usually present with insidious onset symptoms of weakness in 
gripping objects with hands, weakness of fine movements of the hand along 
with tremulousness of the fingers. The muscle weakness preferentially 
involves the intrinsic hand muscles and forearm muscles. This disease for 
unknown reasons spares the brachioradialis. The atrophic region extends 
obliquely over both volar and dorsal surfaces of the forearm which gives the 
characteristic wasting unique to this disease also described as oblique 
amyotrophy. This amyotrophy was initially reported to be a unilateral disease, 
later bilateral  occurrence of the disease have been reported in some patients 
and even among bilateral involvement, it was predominantly observed to be 
asymmetrical. Weakness develops in both extensor and flexor muscles of the 
fingers and wrist; the finger extensors and wrist flexors are usually 
predominantly involved.  Many patients show worsening of finger 
weakness on exposure to cold environment (cold paresis). There are no 
fasciculation at rest, but fascicular twitching of the forearm muscles 
  
 
(contraction fasciculation) accompanies the tremulous movement of the 
fingers on weak finger extension (minipolymyoclonous). Muscle streach 
reflexes of upper and lower limbs are usually normal, although occasionally it 
may be brisk ad rarely there may be pyramidal signs.  
This disease has been predominantly described as a pure motor 
syndrome. Although a few patients show slight hypoesthesia in a localized 
hand region, is usually subjective and objective sensory disturbances are 
rarely observed. This disease doesn’t cause bowel or bladder disturbances, 
cranial nerve dysfunction or autonomic disturbances.  
The clinical course of the disease is usually indolent marked by the 
initial progressive course followed by a spontaneous remission within 2 to 
5 years from onset in most patients. 
The etiology of Hirayama disease is elusive. Till now there have 
been many theories put forth to describe its occurrence, each theory has its 
own lacunae. The important theories that have been implicated till date are 
the following.  
1) Flexion cervical compressive myelopathy
21,22
 
2) Circulatory insufficiency
23,24
 
3) Benign form of spinal muscular atrophy
25
 
  
 
4) Atopy or hyper IgE aemia
26
 
5) Ion channel deficiency 
27 
 
 
    The first autopsy was published by Keizo Hirayama et al in 1987 
revealed arachnoid mater hypertrophy over the anterior spinal cord, 
anteroposterior flattening spinal cord with thinning of lower cervical cord 
at C5-T1 with a predominant lesion in C7-C8 region on both sides. 
Histological examination revealed atrophy of the anterior horns to about 
less than 50% of the normal anteroposterior diameter of the anterior horns 
on both sides of the spinal cord. The lesions showed mild noncavitating 
necrosis in its center with decreased number of nerve cells in the 
surrounding region, degenerative features were observed in the other nerve 
cells, mild astrogliosis without macrophage infiltration. No blood vessel 
proliferation or amyloid deposits. The blood vessels were largely normal. 
These changes were highly localized and the remaining spinal cord 
segments were normal. Based on the Pathologic features of cervical 
poliomyelopathy in this disease, a possible ischemic etiology was thought 
to be responsible for these changes. However, the histopathologic features 
seen in anterior horns  and motor neurons was different from those seen in 
  
 
proven cases of  spinal vascular diseases, confounding the understanding 
of microcirculatory disturbance as a possible pathology. 
   Neuroradiologists after having noted no significant abnormality 
in routine cervical MRI, following the report of possible ischemic changes 
in histopathology, studied dynamic changes in the cervical spine with neck 
flexion in patients of Hirayama disease. The following changes on neck 
flexion were reported - flattening of the lower cervical spinal cord and dura 
which was termed as “over-stretch of the cord”, “tight dural canal in 
flexion”, “forward displacement of the dural sac” or “disproportionate 
shortening of the dorsal roots”. The above findings were hypothesized to 
be responsible for the development of localized cord compression. The 
reason for this localized nature of the disease was thought to be due to 
differential growth of the vertebrae and the spinal cord along with 
meninges during the juvenile growth spurt. This differential growth causes 
anterior cervical cord compression related to flexion movement of the 
neck.  This theory is supported by the observation that the peak age of 
onset of Hirayama disease occurs 2 to 3 years after the peak age of normal 
juvenile growth spurt. 
 
  
 
These dynamic changes of spinal cord flattening and possible 
compression with forward cord shift were predominantly reported in MRI 
done during the early stages / years of the disease. Later during the non 
progressive course of illness, absence of the spinal cord shift anteriorly 
during neck flexion, also suggested that this disease was probably caused 
due to dynamic compression of the lower cervical spinal cord. 
Billé-Turc et al.
(28)
 suggested that Hirayama Disease  is not a 
separate disease by itself and probably represented a  syndrome complex 
characterized by the distinctive clinical features. They also suggested that 
the clinical, electrophysiological or MRI features doesn’t classify 
Hirayama disease as being a distinctive disease and that these features 
could also be interpreted as one of the clinical variants of Benign 
Monomelic Amyotrophy or segmental motor neuron disease.  They 
suggested that this variant can be termed Hirayama’s form of Benign 
Monomelic Amyotrophy. 
 
Several studies on dynamic neck flexion MRI in Hirayama disease 
have consistently reported the anterior shift of the spinal cord and dura 
along with their flattening. This lead to an overwhelming faction of 
  
 
neurologist supporting the mechanical compression
 (29)
 theory of lower 
cervical cord as the most likely contributing factor for the development of 
Hirayama disease.  This along with the reports of several patients having 
arrest of disease progression following use of a cervical collar to restrain 
neck movement also supported this theory
 (30)
.  However still many 
neurologists  do not support or believe in the compressive myelopathy 
theory, as features thought to be exclusively seen in neck flexion MRI 
patients of Hirayama disease was not actually exclusive and  features 
suggestive of  cervical spinal cord compression and increase in space 
behind the posterior dura sleeve were also observed during neck flexion 
MRI in normal people
(31,32)
.  
 
J Kira et. al.
(33)
 observed Hirayama disease cannot be attributed 
solely to mechanical compression of spinal cord hypothesis due to the 
following reasons -  a sudden increased in the reported cases of Hirayama 
disease in Japan during 1990, Arrest in disease  progression spontaneously 
occurring in 1 or 2 years from onset, young males being affected most 
often, few familial case reports and Asians being affected most 
often
(1,6,13,30,32)
. Atopy was hypothesized as one of the precipitants the 
microcirculatory disturbance
(34,35)
 as IgE can cause platelet activation and 
  
 
aggregation 
(36)
, histamine release
(37)
 leading to platelet thrombus formation 
and arterial spasm  causing microcirculatory disturbance. In addition to 
this, venous stasis occurring due to possible spinal cord compression 
during neck flexion can precipitate a local IgE mediated platelet response. 
Repeated episodes of microcirculatory disturbance may lead changes seen 
in the anterior horn cells, as motor neurons are most susceptible to 
ischemia in the spinal cord.  Atopy outbreak in 1990 in Japan can also 
explain the sudden increase in Hirayama disease patients during that 
period. Atopy can also be attributed to familial Hirayama disease as 
familial atopic tendencies are well documented. Also atopic disorders often 
seen in younger individuals and males than compared to the aged and 
females
(38) 
and Asians being more prone to atopy
(39)
 may point to a possible 
alternate theory to partially understand of the epidemiological features of 
Hirayama disease.  
 
  R. M. Van den Berg-Vos et.al.
(40)   
In their attempt to understand 
the pathogenesis of Hirayama disease proposed a classification of adult 
patients with sporadic Lower motor neuron disease as follows 
(i) Slowly progressive Spinal muscular atrophy 
  
 
(ii) Distal spinal muscular atrophy 
(iii) Segmental distal spinal muscular atrophy 
(iv) Segmental proximal spinal muscular atrophy 
  Hirayama disease was considered a distal or proximal segmental 
variants of spinal muscular atrophy. They also observed bilateral upper 
limb involvement described as “man-in-the-barrel” phenomenon together 
with brisk reflexes in 29% of their patients as also noted by Hirayama. 
These findings were also observed in Hirayama disease. In addition, 
involvement of the adjacent lower spinal cord segments, suggests a 
possibility to consider this Lower motor neuron syndrome a variant of 
Spinal Muscular Atrophy.  
 
    Sawai Setsu et. al. 
(27)
 studied Hirayama disease patient and age 
matched controls for conduction properties at normal room temperature 
and after partially cooling the muscle, to study the difference in conduction 
characteristics based on variation of surrounding environmental 
temperature. They observed prolonged strength-duration time constant, 
dispersion of threshold electrotonus, increased refractoriness of muscles 
and supernormality in patients at room temperature and after cooling and 
  
 
in control subjects after cooling. These findings suggested axonal 
depolarization most likely caused due to dysfunction of the sodium – 
potassium pump. Based on these findings they proposed that Hirayama 
disease was caused due to altered axonal excitability of the motor neurons 
due to abnormally increased persistent sodium currents, and dysfunction of 
transient sodium and potassium channels. These findings could possibly 
give partial understanding in the pathogenesis of Hirayama disease and 
phenomenon of cold paresis. 
Laboratory evaluation 
  Clinically patients have patchy wasting of C7, C8, T1 innervated 
muscles namely – wrist extensors, wrist flexors, small muscles of hand, 
hypothenar and some times thenar muscles. There is occasional spread of 
the involvement to C5 and c6 innervated muscles. There is characteristic 
sparing of the brachioradialis muscles and conspicuous absence of 
fasciculation other than minipolymyoclonous. 
 
There are several electrophysiological investigations. 
Electromyography shows acute and chronic denervation in the atrophied 
muscles.  
  
 
1) Motor nerve conduction velocities are normal, except for minimal 
slowing in ulnar nerve conduction.  
2) Amplitude of compound muscle action potentials is reduced in 
the atrophied muscles. 
3) F-wave shows increase in latency, reduced persistence, and a 
single, high-amplitude wave form – suggestive of denervation / 
reinnervation. F-wave persistency decreases and f latency 
increases during flexion of the neck in a progressive phase of the 
disease. 
4) The homonymous muscles of the unaffected side also show 
denervation in about 90% of patients with unilateral amyotrophy. 
Non-atrophic muscles on the affected side sometimes show 
denervation, in 50% of triceps brachii, and in less than 25% of 
brachioradialis, biceps brachii, and deltoid muscles. 
5) Single fiber electromyography shows increased fiber density and 
jitter in a progressive stage. The fiber density further increases but 
jitter decreases in a late, non-progressive stage, indicating 
maturation of reinnervation.  
6) Somatosensory evoked potentials may show abnormal conduction 
through the spinal cord. 
  
 
7) Transcranial magnetic stimulation studies show prolonged latency 
and reduced amplitude of motor evoked potentials. These changes 
are worsened by flexing the neck. Based on this finding cervical 
collar therapy was suggested to prevent neck flexion so that the 
changes associated with neck flexion could be avoided. 
8) Cold paresis is also studied electrophysiologically.  With High 
frequency Repetitive nerve stimulation test of cooled muscle 
showing prolonged latency and low amplitude, suggesting 
impaired conduction through muscle membrane. 
Neuropathology 
1) Muscle biopsy of the atrophic muscles shows typical neurogenic 
changes with clusters of small angular fibers and large type 
groupings indicative of reinnervation 
2) Autopsy is quite rare because of the excellent prognosis of the 
disease compared to the classical motor neuron diseases. The 
spinal cord showed macroscopically evident antero-posterior 
flattening at the lower cervical segments. Microscopically, the 
antero-posterior diameter of the lower cervical anterior horns of 
both sides was reduced, most severely at C7 and C8 
predominantly on the left. The anterior horn lesion was 
  
 
characterized by a decreased number of both large and small 
neurons, mild astrogliosis, and central necrosis without cavity 
formation. The surviving neurons showed various stages of 
degenerative changes. The white matter, posterior horns, and the 
intra- and extramedullary vessels being normal. 
CSF evaluation and its pressure dynamics  
Cerebrospinal fluid shows normal cell content with or without a 
slight increase in protein (40-60 mg/dl; normal <40 mg/dl). Pressure curve 
of the Queckenstedt test shows a slightly slow and insufficient rise and fall 
in the neutral neck position, which is aggravated  during neck flexion. 
Magnetic resonance imaging. 
1) Atrophy or thinning or the spinal cord on sagittal view. 
2) Flattening of the cervical cord in anterior to posterior diameter. 
3) T2 hyperintesity within the spinal cord at anterior horn cell region. 
4) Abnormal curving of the cervical vertebral column. 
5) Detachment of the posterior dural sac from the overlying lamina. 
6) Extension of dural detachment upto upper thoracic level. 
  
 
7) Sickle shaped space behind the dural in cervical region with     
Prominent flow voids 
8) Signal changes noted within the cervical spinal cord. 
Treatment options 
  As yet there is no definitive treatment for Hirayama disease, 
however there are many experimental case reports available in literature 
which can be tried for preventing further progress of disease 
A) Possible suggested treatment options to prevent progression 
1) Medical –  
- Antiglutamate drugs- Riluzole 
       - Cervical soft collar therapy to prevent neck flexion 
     2) Surgical -  
   - Lower cervical laminectomy with neck fusion in partial  
    Extension 
- Lower cervical laminectomy with duroplasty 
B) Functional surgery- tendon transfer surgery to help gain hand function. 
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AIM  
1) To study the clinical, nerve conduction and radiological profile of 
patients diagnosed to have Hirayama disease. 
 
 
OBJECTIVES 
1) To study the clinical profile of Hirayama disease. 
2) To study the changes in Nerve conduction study parameters, 
with respect to median and ulnar  f wave study in the neutral 
position of the neck and flexed position of the neck in patients 
with Hirayama disease and to compare its significance 
between the 2 neck position and also with controls. 
3) To study the MRI changes in patients with Hirayama disease 
in neck neutral position and neck flexion position.  
 
  
 
 
 
 
 
REVIEW OF 
LITERATURE 
  
 
 
REVIEW OF LITERATURE 
 
Hirayama K 
(1,13,.16.17.,18,19,29,30,41)  
described this disease based on the 
clinical presentation as Juvenile muscular atrophy of distal upper extremity 
 (Hirayama disease)  as this disease affected males more often than females 
during their adolescence and it was  characterised  by weakness 
and wasting of muscles of the hand. It usually had a progressive course 
over 2 to 5 years followed by spontaneous arrest.  Based on this 
spontaneous arrest in clinical progression this disease  was proposed by 
him to be a distinct entity when compared to motor neuron disease, 
although he does acknowledge in his article that still many neurologists 
consider this disease to be a variant of neurodegenerative motor neuron 
disease. He interpreted autopsy report published by him,   to be secondary 
segmental ischemic changes restricted to the anterior horn cell region of 
the lower cervical cord.  Based on this cervical ischemic poliomyelopathy 
was the proposed pathogenesis. However, several authors disagree that 
these findings suggest ischemic features and probably degenerative motor 
neuron disease. Hirayama and his colleagues based on the neuropathology 
findings prompted further neuroradiologic investigations post 
  
 
neuropathology findings to support the theory of ischemic cervical 
myelopathy, neck flexion MRI was done, in which dynamic changes of 
anterior shift of cervical spinal canal contents was induced by neck flexion. 
These cervical dynamic changes could not be explained at the present level 
of understanding. Also the number of patients reported to have this disease 
in Japan exceeds 300 and from India exceeds 100, an ethnic factor 
contribution to the causation of this disease was also considered. 
 
Sunil Pradhan
(42)
 evaluated 106 patients in northern India,  the 
author observes that eleven patients, constituting 10% had bilaterally 
symmetrical Hirayama disease and among them 9 patients had asymmetric 
onset of symptoms this being  concluded as unilateral disease progresses to 
severe form of bilateral involvement. They also noted the presence of 
atypical features of localized autonomic dysfunction. MRI of these patients 
revealed the characteristic features described earlier. This study suggested 
a paradigm shift in the understanding of this disease as a unilateral or 
grossly asymmetric disease to that of spectrum of clinical features ranging 
from  unilateral to bilateral disease involvement, in some patients 
progressing to the severe form of bilateral symmetrical  involvement. The 
  
 
author concluded that the description of the term “brachial monomelic 
amyotrophy” should be reviewed as this disease is not strictly monomelic. 
Gourie-Devi M et.al.
(43)
  and Nalini A et.al.
(44)   
Evaluated 17 patients 
diagnosed to have Benign monomelic muscular amyotrophy (Hirayama 
disease), in south India. Somatosensory evoked potential (SSEP) 
recordings were made from both median and ulnar nerve. The dynamic 
changes with respect to recording with a straight neck and flexed neck was 
studied and compared with healthy age matched controls. The author 
observed that in SSEP central conduction in cervical region represented by 
N13 response was abnormal in either or both the nerves in all patients and 
similar changes were absent in the control group. The author concluded 
that with neck flexed position, N13 response was dearanged in 82% 
patients with median nerve SSEP and  100% in ulnar nerve SSEP 
indicating segmental cervical cord dysfunction in patients with Hirayama 
disease. 
 
Lyu RK et. al.
(45)
 studied the median and ulnar  nerve conduction 
among 46  patients with Hirayama disease,  60 patients with  amyotrophic 
lateral sclerosis and 54 healthy subjects for comparison. The author 
  
 
observed that the ulnar to median CMAP amplitude ratio was reduced 
(0.64 ± 0.79) in patients of Hirayama disease when compared with that of 
patients of Amyotropic lateral sclerosis who had higher (2.15 ± 1.77) and 
the normal controls (0.89 ± 0.23). Based on these findings, the author 
concluded that Hirayama disease affected the ulnar nerve segments more 
severely than median nerve segments this was in contrast to patients with 
amyotrophic lateral sclerosis where median nerve segments were more 
affected than the ulnar segments. These observations demonstrate the 
disease specific differential hand muscle wasting between these two 
diseases. 
 
Hemant A Sonwalkar et.al.
(46)
 evaluated the MRI features in eight 
patients with Hirayama disease. The author observed that the only 
consistent finding in his study was of  lower cervical cord atrophy. The 
other findings of asymmetrical atrophy, flattening, loss of normal cervical 
column curvature, dural changes and contrast enhancement was grossly 
variable between patients studied.  In addition to the above findings, they 
observed another variable presentation of thoracic epidural changes in few 
patients. Based on these findings they suggested the use of dynamic post 
  
 
contrast MRI evaluation as a pivotal investigation in the evaluation of 
Hirayama disease patients.  
Nascimento OJ, et. al.,
(47)
 reported 4 cases of Hirayama disease from 
Brazil. They observed Hirayama disease as predominating in Asia and 
rarely referred among westerners.  They followed up the clinical and 
electrophysiological alterations described in these patients over 5 years 
duration. They observed that ENMG suggested LMN pattern of 
involvement. They also analyzed MRI of cervical region in these patients 
to evaluate for possible spinal cord compression; however no abnormality 
was detected in MRI of spine. In view of its clinical, and EMG 
characteristics, they suggested that Hirayama disease is a clinical variant of 
motor neuronopathy - benign monomelic amyotrophy (BMA). They 
concluded that Hirayama disease represented the distal variant, upper limb 
predominant form of benign monomelic amyotrophy and it should not be 
considered to be a specific disease entity in itself.  
 
Fu Y et.,al.,
(48)
 evaluated 27 cases of Hirayama disease  clinically 
and with MRI in dynamic neck positions. They observed that all of their 
patients were right handed and were young males, Of them 77.8% 
  
 
developed initial symptoms before they were 19 years old.  Right hand 
involvement was more common in 20 patients (74%) compared to 7 
patients (26%) with the left hand onset. MRI was abnormal in neutral neck 
position in 16 patients with abnormal cervical curvature and 14 patients 
having lower cord atrophy and 2 having Intramedullary abnormal high 
signals. During neck flexion abnormality was noted in all patients with 
flattening and anterior shift of lower cervical cord with a crescent-shaped 
high signal area behind the cord which showing gadolinium enhancement 
and disappeared after the patient returned to a neutral position in one case. 
They opined dynamic neck flexion MRI are useful diagnosed tool 
revealing significant changes which would be missed on neutral neck 
position MRI. 
 
  U K Misra et.al.
(49) 
 studied 8 Hirayama disease patient and 7 
controls for simultaneous radiological and neurophysiological  correlation. 
They evaluated the effect of neck position in Hirayama disease during 
study of 1)  F waves – in the median and ulnar nerves especially with 
reference to latency, F to M amplitude ratio, F persistence, and 
chronodispersion. 2) Somatosensory evoked potentials (SEPs) - evaluating 
N9, N13, and N20. 3) Magnetic resonance imaging (MRI) – of cervical 
  
 
Spinal cord to look for evidence of characteristic features described earlier.  
They observed that these parameters did not show any significant variation 
in the two neck positions studied in patients of Hirayama disease compared 
with controls. There were minimal change in N13 and this too was not 
attributable to changes observed in the dura.  The author concluded that no 
significant variation of nerve conduction parameters could be observed in 
neck flexion and it was not related to dynamic MRI changes. The author 
suggested that mechanisms different from flexion ischemic myelopathy 
should be explored to understand the occurrence of Hirayama disease. 
 
   S. Pradhan
(50)
 , Tokumaru et. al.
(51)
 observed in their study that   
the forward movement of dura mater occurs only  in the acute phase of 
illness and can press the cervical spinal cord but later during the stable 
phase of the illness, which occurs  1–3 years after the onset of weakness 
and wasting, this compression is not evident. They concluded that  the 
movement of the spinal cord and  dura mater  was due to longitudinal 
stretch occurring with flexion of the neck and their movement being 
independent and not causing compression of the spinal cord. During  this 
stretch the cervical spinal cord mainly abuts the C5, 
C6 vertebral body  probably causing transient compression of radicular 
  
 
arteries feeding that region. They also observed that following detachment 
of the dura the vacant space was filled up with passively dilated venous 
channels. These engorged veins were considered passive dilatation as there 
was not evidence of dural congestion was seen in a patient during surgery. 
They suggested that empty space behind dura had negative pressure that 
favored enlarged epidural veins. Based on this they concluded that 
vascular changes in the spinal cord were due to the positional effect of 
neck flexion and this recurring hemodynamic compromised leads to 
segmental anterior horn cell degeneration in the watershed region.  Dural 
movement was unlikely to cause pressure over the spinal cord and is not 
responsible for the development of this disease.  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
MATERIALS 
AND 
   METHODS 
 
 
 
 
  
 
 
 
MATERIALS AND METHODS 
Study Design:   Retrospective and prospective study 
Setting:  Govt. Stanley Medical College and hospital, Chennai 
600001. 
Study population:     All patients with clinical suspicion of HD between  
                                          Jan 2011 to Jan 2013 were included in the study 
Inclusion criteria: 
1) All patients with hand muscle wasting for whom the etiology could not 
be ascertained on standard evaluation for secondary motor neuron 
disease. 
2) Weakness and wasting predominantly in one or both upper limbs. 
3) Absence of cranial nerve, sphincter or cerebellar deficits.  
4) 5 control subjects, age matched, with no neurological illness,  
 
Exclusion criteria 
  
 
1) Patients with focal upper limb atrophy and weakness due to focal 
disease of nerve, muscle, bone, or maldevelopmental diseases. 
2) Patients of Hansen’s disease. 
3) Patients diagnosed to have traumatic, infectious, vasculitic and 
metabolic plexopathy or neuropathy with hand wasting. 
Methodology 
1) Consent would be taken from subjects and their identity would not be 
revealed. 
2) Review of medical records of patients with a diagnosis of Hirayama 
disease. 
3) Demographic and clinical data of these patients. 
4) MRI cervical spine,  pre- and postcontrast MRI were done with neck in 
neutral position (neck extension) and flexed position (maximum flexed 
position of the neck so as to make the chin touch the sternum) – changes 
in MRI will be recorded as per the description given below. 
5) Nerve conduction study of median and ulnar nerves in neutral position 
(neck extension) and in flexed position of the neck (maximum flexed 
position of the neck so as to make the chin touch the sternum). The 
following parameters would be recorded – compound muscle action 
  
 
potential, f minimum latency, f maximum latency, f mean, f 
chronodispersion – for both ulnar and median nerves. 
6) In patients with Hirayama disease each affected limb is taken as a single 
entity for the purpose of statistical analysis. 
7) Nerve conduction study of median and ulnar nerves in neck neutral 
position (neck extension) and neck flexed position ( maximum flexed 
position of the neck so as to make the chin touch the sternum). The 
following parameters would be recorded – compound muscle action 
potential, f minimum latency, f maximum latency, f mean, f 
chronodispersion – for both ulnar and median nerves. 
8) Comparison of  f mean in median and ulnar nerves of affected limbs 
with that of controls and also comparison between the f mean in 
Hirayama disease patients in neck extension and flexed position to look 
for significance in the variation. 
Magnetic resonance imaging  
   Magnetic resonance imaging will be performed at Govt. Stanley 
hospital with a 1.5 Tesla MRI scanner (Siemens).  
   MRI protocol based on available literature was formulated by the 
radiology and the following imaging protocol was planned to be performed 
on each patient. Imaging was performed in 2 neck positions 
  
 
1) Patient lying straight on the scanner with the neck in extension / 
neutral position. 
2) The patient lies straight on the scanner, bending his neck forward 
as far as possible so as to touch the sternum with his or her chin 
and the head being supposed in this position with the help of MRI 
compatible pillows. 
In the above mentioned position the following sequences were 
performed as follows 
1) Neck straight - Sagittal SE T1W, TSE T2, Gradient Echo T2. 
2)  Neck in flexed position - Sagittal SE T1W, TSE T2, Gradient 
Echo T2, Postcontrast SE T1W was done in the sagittal plane 
using gadolinium based MR contrast at a dose of 0.5mmol/Kg 
body weight of the patient as a rapid bolus injection via a 
venous access.   
 
  The images were interpreted by radiologists and they were given 
the necessary clinical information. The following features were 
evaluated in patients with Hirayama disease. 
1) Atrophy or thinning or the spinal cord on sagittal view. 
  
 
2) Flattening of the cervical cord in antero posterior diameter. 
3) T2 hyperintensity within the spinal cord at anterior horn region. 
4) Abnormal curving of the cervical vertebral column. 
5) Detachment of the posterior dural sac from the overlying lamina. 
6) Crescent shaped space behind the dural in cervical region. 
7) Gadolinium enhancement of this space. 
8) Intramedullary signal hyperintensity.  
       The above mentioned features are defined and identified based on 
similar descriptions in the literature described below. 
1) The localized atrophy of the cervical spinal cord was usually seen 
in the spinal cord adjacent to C4 and C7 vertebrae. 
2) Cord atrophy was measured in sagittal T1/ T2 imaging by 
measuring anterior to posterior spinal cord diameter in the upper 
cervical,  lower cervical and upper thoracic region. Atrophy was 
said to be present if the lower cervical spinal cord diameter was 
equal or less the other diameter of the spinal cord measured above 
or below
(52)
.  
3) On axial imaging of the spinal cord atrophy of the cord was 
observed as follows. The normal spinal cord is round to elliptical 
  
 
in cross section. Unilateral or asymmetrical atrophy of the spinal 
cord appears like a pear fruit with thinning on one half and 
rounded configuration on the other side. Bilateral atrophy was 
characterized the flattening of the postero-lateral aspect of the 
spinal cord giving a cross sectional configuration of a triangle. 
4) Flattening was evaluated on axial MR images.  The spinal cord is 
defined as anterior- posteriorly flattened only if there is no 
obvious evidence of cord compression with the surround CSF 
space of equal width all around the spinal cord
 (52)
.  
5) The cervical curvature was evaluated based on the description 
suggested by Batzdorf and Batzdorff. 
(53)
. With the neck in a 
neutral position in T1 sagittal imaging an imaginary line was 
drawn from the posterior border of the body of the C2 vertebrae to 
the level of posterior border of the C7 vertebrae. The intervening 
vertebrae are normally anterior to the imaginary line. If they touch 
the imaginary line or cross posterior to it then the normal lordotic 
curvature of the cervical spine is said to be lost. 
6) Detachment of the dura from the overlying lamina is best observed 
in T2 sagittal and T2 axial imaging of the spinal cord with neck in 
flexion. More than one-third loss of attachment between the 
  
 
posterior dural sac and the subjacent lamina was considered 
significant
(52)
. 
7) Normally no T2 signal changes are seen within the spinal cord in 
T2 sagittal or axial view.  Hyperintensity in the area of anterior 
horn cells of the spinal cord, without any evidence of 
compression, is considered abnormal cord hyperintensity. 
8) On injecting Gadolinium contrast, enhancement in normal 
individuals. Enhancement of the space behind the detached dural 
is considered abnormal and is suggestive of vascular channels in 
this region. 
Statistical analysis 
Statistical analysis was performed using SPSS 17.0 software. CMAP 
(compound muscle action potential) and f wave latency of the median and 
ulnar nerves of the affected limb and control limb were fed into the 
software and verified the data to be parametric. Mean and standard 
deviation was derived. The independent variable t test was performed. A 
probability level less than 0.05 was considered to be significant.  
 
 
  
 
 
 
 
 
RESULTS 
  
 
OBSERVATIONS & RESULTS 
1) In this study there was a male preponderance in Hirayama disease 
patients, with 27 (87.1%) of males and 4 (12.9%) of females (fig. 1). 
 
 
 
 
 
 
Figure 1: Gender distribution of patients with Hirayama disease 
 
2) Hirayama disease was unilateral in 9 (29%) patient and bilateral in 22 
(71%) patients (figure 2). Among females all 4 (100%) patient had 
bilateral involvement and among males 9 (33.3%) of 27 had unilateral 
and 18 (67.7%) had bilateral involvement of upper limbs (figure 2). 
 
 
 
 
Figure 2: Gender variation of unilateral or bilateral disease involvement 
  
 
3) All patients were right handed people. Among 9 patients with unilateral 
disease, 5 (55.6%) had right upper limb affected and 4 (44.4%) had left 
upper limb involvement (figure 3). 
 
 
 
                         Figure 3: Hand involved in unilateral disease 
4) Among 22 patients with  bilateral disease, right upper limb was more 
affected than left in 12 (54.5%), left upper limb was more affected than 
right in 8 (36.4%) and bilateral equal affected upper limb was seen in 2 
(9%) patients (figure 4). 
   
 
 
 
 
Figure 4: Predominant Hand involvement in bilateral disease 
  
 
5) Among the 31 patients studied (table 1), 27 patients had right hand 
involvement and 26 patients had left hand involvement. Although 
bilateral the hand involvement in this disease is asymmetrical 
Predominant right hand involvement was seen in 17 (55%) patients (5 
with unilateral and 12 with bilateral disease) compared to predominant 
left hand involvement 12 (39%) and 2 (6%) patients had bilateral equal 
involvement of hand.  
Table 1:  Overall Predominant hand involved in Hirayama disease 
  
 
 
6) The age of the patients (figure 5) in this study ranged from 15 years to 
30 years with a mean age of 21.5 years. 
 
 
 
 
Figure 5: Age distribution of Hirayama disease patients 
Predominant hand affected No of patients  Percentage  
Right hand affected 17 55% 
Left hand  affected 12 39% 
Both had equally affected 2 6% 
  
 
7)  The duration of disease (figure 6) in the patients studied varied from 3 
months (0.25 years) to 108 months (9 years) with an average duration of 
31.7 months (2.65 years).  
 
 
 
 
Figure 6: Duration of disease in patients with Hirayama disease. 
8) Age at onset of first symptom (figure 7) in the study population varied 
from 11 years of age to 27 years of age with the average age of disease 
onset being 18.9 years. 26 (84%) patients had onset of disease between 
the age of 15 to 25 years. 
 
 
 
 
Figure 7: Age at first symptom of Hirayama disease 
  
 
9) A history of acute worsening of weakness on overnight exposure to cold 
environment was present in 8 (25%) patients (figure 8), all of them had 
unilateral disease and had disease duration of 3 months to 18 months. 
This pattern may suggest that cold paresis is a feature of early stage of 
the disease than compared to later stages. 
 
 
 
 
       Figure 8: Clinical history of cold paresis in Hirayama disease patients 
10) All patients had wasting, weakness, tremulousness of distal upper 
limbs. In addition, 11(35%) patients (Figure 9) had proximal 
involvement.  
 
 
 
Figure 9- Patients of Hirayama disease with proximal involvement 
  
 
11) All patients had moderate to severe involvement of C8, T1 
myotomes, 27(87%) patients had involvement of C7 myotome and 11 
(35%) patients had C5, C6 myotome involvement ( figure 10).  
 
 
 
 
 
           Figure 10: spinal segment involvement in Hirayama disease patients 
12) Brisk deep tendon reflexes were observed in 11 (35%) patient in 
the lower limbs and the rest 20 (65%) had normal DTR (figure11). 
 
 
 
 
 
Figure 11:  DTR response in Hirayama disease patients 
  
 
13) Transient benumbed sensation of the affected limb over the 
dorsum of the hand lasting few days to week with spontaneous recovery 
was seen in 6 (19%) patients.  5 Of them had unilateral disease and this 
sensory disturbance was associated with cold paresis. Sensory nerve 
action potential was normal. 
 
 
 
Figure 12: Sensory symptoms in patients of Hirayama disease 
14) Fasciculation over deltoid, biceps or triceps was seen in 8 (26%) 
patient (figure 13), they had bilateral disease and disease duration of 
more than 24 months. This feature may be suggestive of active 
denervation during the early proximal disease innervation. 
 
 
 
Figure 13: Clinically evident fasciculation in Hirayama disease patient 
  
 
15) 11 (35%) patients had weakness of deltoid and biceps muscles. 
Triceps was weak in 27(87%). All patients had wrist flexion weaker 
than wrist extension. All patients had severe weakness of FDP compared 
to FDS.   
16) All patients had wasting of the intrinsic muscles (figure 14) of the 
hand which was asymmetric or patchy, which was characteristically 
evident on inspection of an outstretched hand revealing each finger in 
different planes suggesting an imbalance in muscle strength causing 
fingers to project in different planes. Regarding forearm wasting, there 
was evident wasting of the medial aspect of the forearm with flexor 
digitorum profundus more weak compared to flexor digitorum 
superficialis especially of the 4
th
 and 5
th
 digit. Lateral forearm was 
spared with normal preserved bulk of brachioradialis in all patients. 
 
   Figure 14: Bilateral Hirayama disease – hand muscle wasting 
  
 
17) On MRI sagittal images, all 31 patients had straightening of the 
cervical spine from C3 to C6 vertebra  MRI (figure 15-image A & B) 
with loss of cervical lordosis in neck neutral position.  
 
    
Image A     Image B 
Figure 15: T1W (image A) & T2W (image B) MRI showing 
loss of cervical lordosis 
  
 
18) Lower cervical cord atrophy (figure 16) on MRI sagittal image 
was seen in 25 (80.6%) patients, remaining 6 (19.4%) patients who did 
not have lower cervical cord atrophy on sagittal plane had unilateral 
disease. 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Atrophy of cervical cord at the level of C4 to C7 vertebral level. 
 
  
 
19) Intramedullary hyperintensity on MRI T2W sagittal (figure 17) 
and axial sections were seen in 5 (16.1%) patients of them all 5 were 
having bilateral disease of more than 5 years duration. 
 
 
Figure 17: T2 Sagittal MRI shows intramedually T2 hyperintensity within  
the lower cervical spinal cord. 
  
 
20)  In MRI T2W gradient spin axial view of cervical spinal cord, 2 
(6.5%) patients had a normal elliptical shape (figure 18 A) of the cord; 
they had unilateral disease of less than 1 year duration. 22 (70.9%) 
patients had triangular (figure 18 B) cross section of spinal cord 
suggestive of symmetric bilateral cord atrophy corresponding with the 
bilateral nature of their disease. 7 (22.6%) patients had pear shaped cord 
cross section suggesting asymmetric cord atrophy (figure 18 C) 
corresponding with unilateral disease, with atrophy of the cord towards 
the affected limb side.  
 
Figure 18 A: Normal elliptical axial T2W cervical spinal cord. 
 
  
 
 
Figure 18 B: Triangular cervical cord atrophy evident on T2W Axial MRI 
 
  
Figure 18 C: Asymmetric cord atrophy - pear shaped on axial T2W MRI 
 
  
 
21) On sagittal MRI T2W imaging in neck flexion, anterior 
displacement of the lower cervical cord (figure 19) was seen in 27 
patients (87.1%) and absent in 4 patients (12.9%). 
 
 
Figure 19:  Anterior displacement of cervical cord on neck flexion 
 
  
 
22) On Sagittal MRI T1W images in neck flexion position, anterior 
buckling of the posterior lower cervical dura ( Figure 20- image A) with 
flow voids in the post dural space was seen in 27 patients (87.1%) of 
them 2 had extension of the post dural space upto T4 to T6 vertebrae 
(Figure 20- Image B). 4 patients did not have anterior buckling of the 
posterior lower cervical dura. 
  
Image A     Image B 
Figure 20: T2W sagittal imaging in neck flexion  
Image A – anterior buckling of posterior dura.  
Image B - dural detachment upto T6 vertebrae  
  
 
23) MRI T1W sagittal sections in neck flexion (figure 21- image A) 
with contrast, showed contrast enhancement (Figure 21- image B) of 
post dural flow voids were seen in 27 patients. 4 patients who did not 
have anterior buckling of the posterior dura did not show any change 
with contrast injection. 
  
   Image A    Image B 
Figure 21: T1W sagittal neck flexion images 
Image A: apparently normal looking T1W image 
Image B: Post contrast enhancement behind dura. 
  
 
24) The median distal latency was normal in all patients, there was 
significant reduction in CMAP amplitude of median nerve (p=0.001) on 
comparison of Hirayama disease patients with that of normal controls 
(table 2).  In 3 patients, 2 had unilateral median nerve being not 
stimulatable and 1 had bilateral non stimulatable median nerve.  
Table 2: Comparison of CMAP of median nerve in patients with 
Hirayama disease and normal controls 
 
Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
CMAP -  
Median 
Disease 49 9.8061 4.99335 0.71334  
p=0.001 Normal 10 16.6400 3.75742 1.18820 
 
25) The Ulnar nerve distal latency was normal in all patients, there 
was significant reduction in CMAP amplitude of ulnar nerve (p=0.001) 
on comparison of Hirayama disease patients with that of normal 
controls(table 3). 2 patients had bilaterally not stimulatable ulnar nerve. 
Table 3: Comparison of CMAP of Ulnar nerve in patients with 
Hirayama disease and normal controls 
 
Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
CMAP-  
Ulnar 
Disease 49 4.7122 3.78773 0.54110  
p=0.001 Normal 10 11.9000 1.65999 0.52493 
 
  
 
26) The f latency of median nerve (table 4) and ulnar  (table 5) nerve 
of controls did not show any significant change on comparison of neck 
extension values with neck flexion values. Median nerve (p=0.293)  and 
ulnar nerve (p = 0.293) 
Table 4: Comparison of median f latency in normal controls in 
neck extension / neutral position and flexion position 
Normal 
Controls Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
Median 
Extension 10 26.1790 0.96791 0.30608  
 p=0.293 Flexion 10 26.7820 1.46843 0.46436 
 
Table 5: Comparison of ulnar f latency in normal controls in neck 
extension / neutral position and flexion position 
Normal 
controls Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
Ulnar 
Extension 10 25.7180 1.51738 0.47984  
p=0.718 Flexion 10 26.0320 2.24718 0.71062 
 
 
27) In 31 patients there were 53 affected limbs (22 bilateral diseases 
& 9 unilateral diseases). Of the 53 limbs, median nerve was not 
stimulatable in neck extension position in 4 limbs (49 limbs stimulatable 
for median nerve in extension) and in neck flexion positions in 10 limbs 
  
 
(43 limbs stimulatable for median nerve in flexion). The non 
stimulatable limbs were excluded from statistics. 
28) There was no significant difference of  f wave latency of median 
nerve (table 6) in patients of Hirayama disease and controls with the 
neck in flexion studies with p = 0.089. 
Table 6: Comparison of Median f latency in Hirayama disease and 
normal controls in neck flexion position 
Neck 
flexion Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
median 
Disease 43 30.4695 6.63251 1.01145  
p=0.089 Normal 10 26.7820 1.46843 0.46436 
 
29) There was a significant change in f wave latency of median nerve 
(table 7) in patients with Hirayama disease with the neck in extension / 
neutral position p = 0.001. 
 
 
 
 
 
 
 
 
 
 
 
Table 7: Comparison of median f latency in Hirayama disease 
and normal controls in neck neutral position 
Neck 
neutral Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
Median 
Disease 49 30.2118 1.30416 0.18631  
p=0.001 Normal 10 26.1790 0.96791 0.30608 
  
 
30) There was no significant change in f latency of median nerve 
(table 8) in patients of Hirayama disease on comparison of values in 
neck extension and neck flexion (p = 0.791).  
Table 8: Comparison of Median f latency in Hirayama disease in 
neck extension / neutral position and flexion position 
Hirayam
a disease Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
Median 
Extension 49 30.2118 1.30416 0.18631  
p=0.791 Flexion 43 30.4695 6.63251 1.01145 
 
31) Among 31 patients there was 53 affected limbs (22 bilateral and 9 
unilateral) in them ulnar nerve was not stimulatable in 4 limbs in neck 
neutral/extension position & were excluded leaving 49 limbs for 
analysis & 12 were not stimulatable in flexion leaving 41 for analysis. 
32) Ulnar nerve f latency was  significant different(table 9) in patients 
of HD & controls with neck in neutral position / extension, p = 0.001. 
Table 9: Comparison of Ulnar f latency in Hirayama disease and 
normal controls in neck neutral position 
Neck 
neutral Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
Ulnar 
Disease 49 31.2400 1.36212 0.19459  
p=0.001 Normal 10 25.7180 1.51738 0.47984 
 
  
 
33) There was a significant increase in f wave latency of ulnar nerve 
(table 10) in patients with Hirayama disease than compared to controls 
with neck in flexion (p = .001). 
 
Table 10: Comparison of Ulnar f latency in Hirayama disease and 
normal controls in neck flexion position 
Neck 
flexion Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
Ulnar 
Disease 41 33.4399 .92482 0.14443  
p=0.001 Normal 10 26.0320 2.24718 0.71062 
 
 
34) There was a significant change in f wave latency of ulnar nerve 
(table 11) in patients with Hirayama disease with the neck in flexion 
compared to  in extension / neutral position (p = 0.001). 
Table 11: Comparison of ulnar f latency in Hirayama disease in 
neck extension / neutral position and flexion position 
Hirayama 
disease Coding N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Independent 
sample t test 
f latency 
Ulnar 
Extension 49 31.2400 1.36212 0.19459  
p=0.001 Flexion 41 33.4399 0.92482 0.14443 
 
  
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
DISCUSSION 
 
Hirayama disease is a disease predominantly affecting the males. In 
this study too there was a male preponderance of with 87% patients 
compared to 13 % of female patients. This disease affects individuals in 
the age group of 2
nd
 to 3
rd
 decade, in our study the age of disease onset 
varied from 11 to 27 years with an average age of disease onset of 18.9 
years.  These observations in our study are consistent with the data 
reported from other studies
(30.54)
.  Although there is no definitive 
explanation available at present to account for this disproportionately high 
male preponderance of cases and onset of disease in the 2
nd
 decade of life, 
however there are some proposed indirect evidence for this clustering as 
follows. 
The average pubertal spurt in growth occurs in the early to mid 
teenage, and this growth spurt is more in males compared to females. Also 
it is interesting to note that the growth spurt precedes the onset of 
Hirayama disease onset by 4 to 6 years. It is hypothesized based on these 
findings that the male preponderance could result from the rapid increase 
in the height of boys
(54,55)
 leading on to disproportionate growth of the 
  
 
vertebral column and the contents of the spinal canal during puberty leads 
to the development of microcirculatory disturbance in lower cervical spinal 
cord  during neck flexion 
(56,57,58,59,61)
. This mechanism also supports one of 
the proposed explanations for the pathogenesis of cervical flexion 
myelopathy producing Hirayama disease. The differential growth rates 
between males and females have been previously proposed by       Thoma 
et.al
(60,61)
. Also the disproportionate dural shortening accentuated during 
growth spurts in juveniles explains the adolescent onset of Hirayama 
disease 
(60,61)
. 
 
In this study 19 patients were students, 10 patients were manual 
laborer or auto driver, 2 patients were housewife. The preponderance of 
cases in students could be explained by 2 major reasons. The first, this 
being a disease of late 2
nd
 to early 3
rd
 decade, the age when most are in 
their student life. The other factor that can be proposed is that students 
while reading from book have a tendency to keep the neck flexed and 
study, both these factors the age and neck flexor are already explained 
above for the development of Hirayama disease.  
 
  
 
     Hashimoto et. al., 
(62)
 have reported that strenuous exercise of the 
arms was a frequent association with their patients. Biondi et. al., 
(63)
 
reported that repeated subclinical cervical trauma is a cause of chronic 
microcirculatory disturbances. Therefore, strenuous physical activity over 
a long duration could be a risk factor for Hirayama disease. This 
explanation can be applied for development of Hirayama disease in manual 
laborers and auto driver. 
 
    These patients predominantly present with insidious onset slowly 
progressing wasting and weakness of the hand and forearm associated with 
tremulousness of the fingers of the affected limb. In our study 8 (25.1%) 
patients had acute worsening of weakness in the background of slowly 
progressing weakness, especially with exposure to cold. This phenomenon 
of cold paresis is thought to occur due to sodium potassium ion channel 
dysfunction on exposure to cold. Sawai Setsu et. al 
(27)
 have studied this 
phenomenon and proposed that increased persistent sodium channel 
function and reduced transient sodium channel and potassium channel 
function in motor axon neurons leads to axonal dysfunction and if 
persistent can lead to neuronal damage. In this study all 8 patients with 
cold paresis had disease duration ranging from 3 to 18 months. This 
  
 
pattern suggests that cold paresis is a feature of the early stage of 
Hirayama disease and it indicates ongoing neuronal dysfunction and 
probably damage which could be preventable if appropriate treatment 
strategies are applied at this stage of disease. 
 
Predominant right hand involvement was seen in 17 (55%) patients 
(5 with unilateral and 12 with bilateral disease) compared to predominant 
left hand involvement 12 (39%) and bilaterally equal involvement of hand 
in 2 (6.5%). These observations too might support the hypothesis that 
strenuous physical activity could have a role in causation of Hirayama 
disease as all the patients in this study were right handed. 
 
   In this study bilateral involvement of upper limb was seen in 
18(67.7%) patients. Though initially Hirayama disease was thought to be a 
unilateral disease, later studies have demonstrated asymmetric bilateral 
involvement. Proximal upper limb wasting was present in 11 (35.5%) 
patients and 8 had fasciculation in proximal arm, 2 years after onset of 
illness, suggestive active progressive disease involving the proximal upper 
limb later in the course of Hirayama disease. 
  
 
 
  Nerve conduction study of patients with Hirayama disease reveals 
reduced CMAP in median and ulnar nerve in patients with atrophy of the 
muscle supplied by these nerves. Severely atrophic muscles were not 
stimulatable in few patients.  
 
  In this study there was a significant difference in f wave latency 
of median and ulnar nerve in patients and controls, and also significant 
prolongation in f wave latency in ulnar nerve on neck flexion compared to 
neck extension with a variation in f latency of up to 6 milliseconds in 
patients with Hirayama disease. However in normal control this variation 
was usually less than 1 millisecond. This phenomenon was not observed in 
ulnar nerve conduction in normal controls. With regards to median nerve 
conduction there was no significant variation in either patients with 
Hirayama disease or normal controls in neck flexion or extension.  Similar 
f wave changes were reported by WANG Xin-ning et. al.,
(54)
. However,  
Misra et. al., 
(49)
 and Ammendola et. al., 
(64)
 have reported the effect of 
neck flexion in Hirayama disease on changes in N13 and f wave 
parameters. They concluded based on their study that there was no 
  
 
significant difference in these parameters in standard conditions and neck 
flexion.  
     This variation of f latency can be explained based on the dynamic 
flexion myelopathy theory, as during neck flexion there would be 
compression of the lower cervical cord in the region of C8, T1 (which 
corresponds more with ulnar nerve distribution than median nerve) causing 
microcirculatory disturbance in the region supplying the anterior horn cell 
region and probably leading to conduction disturbance.  
 
   On MRI sagittal view in neutral position there was loss of 
cervical lordosis and straightening of cervical vertebral column in all 
patients. In neck flexed position, anterior shift of spinal cord abutting the 
vertebral column was also seen in 27 patients, which was not evident on 
neck extended view. No specific correlation between duration, severity of 
disease, unilateral / bilateral disease or anterior shifting of the spinal cord.  
 
Hirayama K
(30)
,  Tokumaru Y et.al.
(29)
 and tang et.al.
(65)
 have 
reported similar findings in their study and have recommended cervical 
collar therapy for preventing progression of cervical flexion myelopathy. 
  
 
However Robberecht W et.al.
(31)
 and Schröder R et.al.
(32)
 have reported 
compression and an anterior shift of lower cervical cord and posterior dura 
along with increased epidural space in normal subjects in neck flexion.  
 
In Sagittal view of cervical spinal cord, lower cervical atrophy, 
characterized by loss of  cervical widening or thinning of the cord in the 
lower cervical region compared to upper cervical or upper thoracic spinal 
cord diameter was seen in 25 patients and most of them had bilateral 
disease. Patients who did not have evident spinal cord atrophy on the 
sagittal view had unilateral disease.  In patients with early disease of < 6 
months duration cervical spinal cord atrophy on axial view was not seen 
(in 2 patients) in the rest, patients with unilateral disease had asymmetric 
spinal cord atrophy resembling a pear fruit with the narrow side towards 
the affected side and the wider side towards the normal hand, patients with 
bilateral atrophy had triangular atrophy of the spinal cord on axial section. 
Shinomiya et.al.,
(66)
 proposed that “posterior epidural ligament factor” for 
asymmetric cord atrophy. They proposed presence of two kinds of 
ligaments between ligamentum flavum and posterior dural sac. One being 
fine and the other being large. The large ligament resists against separation 
  
 
of posterior dura. Abnormal and unequal distribution of these ligaments 
may lead to asymmetric spinal cord compression. 
 
On MRI in neck flexion there is a evident anterior shift of posterior 
dura in 27 patients in this study, as a consequence of this there was 
cresentic epidural space seen containing flow voids, which enhance on 
contrast administration, suggesting engorged venous channels in the 
epidural space. These findings support the microcirculatory disturbance 
theory due to venous congestion and also compressive flexion myelopathy 
 
The above findings on MRI have been reproduced on several studies 
from India and abroad  by Pradhan S et.al.
(56)
, Hassan KM et.al.
(61)
,  
Kikuchi S et.al.
(58)
, Mukai E et.al.
(59)
, Biondi A et.al.
(63)
, Ammendola A 
et.al.
(64) 
. Based on these findings it is not clear if these dynamic changes 
are the “cause” for the development of compressive segmental damage or 
the “effect” occurring secondary to secondary to primary segmental motor 
neuronopathy.  
 
  
 
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
 
  
 
SUMMARY OF RESULTS 
 Males are predominantly affected with M : F = 7 : 1 
  70% of patients have bilateral involvement. 
 55% of patients have predominant right hand involvement. 
 Average age at onset of first symptom is 18.9 years. 
 Overnight exposure to cold environment induced worsening of 
weakness was seen in 25 % of patients. This phenomenon is seen in 
patients with disease duration of less than 18 months. 
 In this study 19 % patients had transient sensory disturbance usually 
associated with phenomenon of cold paresis. 
 Hirayama disease predominantly involves distal upper limbs, but in 
this study 35% of patients additionally had proximal upper limb 
involvement. 
 In this study brisk DTR was observed in 35% of patients. 
 Proximal muscle fasciculation was present in 25% of patients. 
 Ulnar nerve F latency is prolonged and is accentuated significantly 
in neck flexion. 
 Median F latency is also prolonged but is not significantly 
accentuated on neck flexion. 
  
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
 
  
 
CONCLUSION 
 
  In this study, in addition to the features originally described by 
Kiezo Hirayama, atypical features such as bilateral involvement, 
proximal muscle wasting, sensory symptoms, fasciculation and brisk 
DTR were observed. 
 
   This study also concludes that in Hirayama disease ulnar nerve 
conduction studies of mild prolongation of the f wave latency which is 
accentuated on neck flexion will characterize this disease. This feature 
can be used as a monitoring parameter and also to objectively record 
progress during therapy. 
 
  MRI of the cervical spine in Hirayama disease patients with neck 
in neutral position is often reported as normal. It is an essential tool to 
rule out secondary treatable causes of compressive or non compressive 
myelopathy. Dynamic neck flexion MRI highlights the characteristic 
features of Hirayama disease.  
  
 
 
 In this study despite the smaller sample size it can be concluded 
that the presence of atypical features, predominant right hand 
involvement in young males, ulnar f wave changes and MRI changes are 
characteristic features and not pathology of the disease. 
 
The pathogenesis of Hirayama disease is still an enigma wrapped 
in a mystery with a possibility of segmental neuronal damage due to 
mechanical disturbance of integuments, vascular compromise and / or 
degenerative processes. Hence decompressive procedures are debated. 
To facilitate preservation of hand function and quick rehabilitation,  
cervical collar application may be of immense help to patients with` 
Hirayama disease. 
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MASTER CHART – PATIENTS WITH HIRAYAMA DISEASE – PART 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
sl.  
No. Name 
Neuro 
no. Age Gender Occupation Handedness 
Disease 
Duration 
(months) 
age of  
onset 
(years) 
cold  
pares
is 
Unilateral 
/ bilateral Right Left  R / L 
1 Karthik 2103/11 18 Male Student Right 6 17.5 yes Unilateral No yes Left 
2 Balaji 2963/11 30 Male auto driver Right 96 22 no Bilateral Yes yes left > right 
3 Devi 1850/11 25 Female house wife Right 24 23 no Bilateral Yes yes right > left 
4 Augustine 6190/10 22 Male Student Right 24 20 yes Bilateral Yes yes right > left 
5 Babu 7124/10 18 Male Student Right 24 16 no Bilateral Yes yes left > right 
6 Rajesh 1368/11 20 Male Student Right 3 19.75 yes Unilateral Yes no Right 
7 Karthikeyan 6839/10 21 Male Student Right 24 19 no Bilateral Yes yes right > left 
8 Arthi surya 512/11 20 Female Student Right 108 11 no Bilateral Yes yes right > left 
9 Karthik 3178/11 19 Male Student Right 18 17.5 no Unilateral Yes no Right 
10 Vivek 6780/10 15 Male Student Right 12 14 no Bilateral Yes yes right > left 
11 Suman 2124/11 18 Male Student Right 24 27 no Unilateral Yes no Right 
12 Ramamurthy 4219/11 26 Male labrour Right 60 21 no Bilateral Yes yes left > right 
13 Alagappan 3195/11 22 Male auto driver Right 6 21.5 yes Unilateral No yes Left 
14 Manikandan 1290/12 19 Male labrour Right 36 16 no Bilateral Yes yes right = left 
15 Suresh kumar 2197/11 23 Male student Right 18 21.5 no Bilateral Yes yes left > right 
16 Ramachandran 1570/12 24 Male auto driver Right 24 22 no Bilateral Yes yes right > left 
17 Jagdish 342/12 19 Male student Right 6 18.5 yes Unilateral No yes Left 
18 Ansari 3212/12 28 Male auto driver Right 96 20 no Bilateral Yes yes left > right 
19 Usha 2892/11 22 Female house wife Right 24 20 no Bilateral Yes yes right > left 
20 Giri 6512/12 21 Male student Right 24 19 yes Bilateral Yes yes right > left 
21 Arulraj 4589/12 18 Male student Right 24 16 no Bilateral Yes yes left > right 
22 Vijaykumar 2168/12 20 Male student Right 12 19 yes Unilateral Yes no Right 
23 Raja 5400/11 21 Male student Right 24 19 no Bilateral Yes yes right > left 
24 Meena 7810/11 20 Female student Right 60 15 no Bilateral Yes yes right > left 
25 Arjunan 1637/12 16 Male student Right 12 15 no Bilateral Yes yes right > left 
26 Durairaj 5423/12 19 Male student Right 24 17 no Unilateral Yes no Right 
27 Darshan 1275/11 25 Male labrour Right 42 21.5 no Bilateral Yes yes left > right 
28 Moorthy 3164/12 21 Male auto driver Right 9 20.25 yes Unilateral No yes Left 
29 Dinesh 1260/12 19 Male labrour Right 36 16 no Bilateral Yes yes right = left 
30 Ram kumar 6410/12 21 Male student Right 24 19 no Bilateral Yes yes left > right 
31 Chandran 2174/12 23 Male auto driver Right 24 21 no Bilateral Yes yes right > left 
  
 
                                                       MASTER CHART – PATIENTS WITH HIRAYAMA DISEASE – PART 2 
 
 
 
 
sl.  
No. Weakness Wasting Distal proximal  Tremulousness Fasciculation Deltoid Biceps 
Brachio- 
Radialis triceps FDS FDP 
1 Yes Yes Yes Yes yes Yes Mild Moderate Normal moderate moderare moderate  
2 Yes Yes Yes Yes yes Yes Mild Mild Normal moderate normal moderate 
3 Yes Yes Yes Yes yes Yes Mild Mild Normal normal normal mild 
4 Yes Yes Yes No yes No Normal Normal Normal moderate normal mild 
5 Yes Yes Yes No yes No Normal Normal Normal moderate normal mild 
6 Yes Yes Yes No yes No Normal Normal Normal Mild normal mild 
7 Yes Yes Yes No yes No Normal Normal Normal moderate normal mild 
8 Yes Yes Yes Yes yes Yes moderate Moderate Normal moderate mild mild 
9 Yes Yes Yes Yes yes Yes moderate Moderate Normal moderate moderate moderate 
10 yes Yes Yes No yes No Normal Normal Normal moderate normal mild 
11 yes Yes Yes No yes No Normal Normal Normal moderate normal mild 
12 yes Yes Yes Yes yes Yes moderate Moderate Normal moderate moderate moderate 
13 yes Yes Yes No yes Yes Normal Normal Normal normal normal mild 
14 yes Yes Yes No yes No Normal Normal Normal moderate moderate severe 
15 yes Yes Yes No yes No Normal Normal Normal moderate mild moderate 
16 yes Yes Yes No Yes No Normal Normal Normal moderate mild moderate 
17 yes Yes Yes Yes Yes Yes Mild Moderate Normal moderate moderare moderate  
18 yes Yes Yes Yes Yes Yes Mild Mild Normal moderate normal moderate 
19 yes Yes Yes Yes Yes Yes Mild Mild Normal normal normal mild 
20 yes Yes Yes No Yes No Normal Normal Normal moderate normal mild 
21 yes Yes Yes No Yes No Normal Normal Normal moderate normal mild 
22 yes Yes Yes No Yes No Normal Normal Normal Mild normal mild 
23 yes Yes Yes No Yes No Normal Normal Normal moderate normal mild 
24 yes Yes Yes Yes Yes Yes moderate Moderate Normal moderate mild mild 
25 yes Yes Yes No Yes No Normal Normal Normal moderate normal mild 
26 yes Yes Yes No Yes No Normal Normal Normal moderate normal mild 
27 yes Yes Yes Yes Yes Yes moderate Moderate Normal moderate moderate moderate 
28 yes Yes Yes No Yes Yes Normal Normal Normal normal normal mild 
29 yes Yes Yes No Yes No Normal Normal Normal moderate moderate severe 
30 yes Yes Yes No Yes No Normal Normal Normal moderate mild moderate 
31 yes Yes Yes No Yes No Normal Normal Normal moderate mild moderate 
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Sl.  
No. 
Wrist  
extensor 
 / flexor 
Intrinsic 
muscles  
of hand C5 C6 C7 C8 T1 DTR 
Sensory 
Sympt 
Straight 
C3-C6 
Sagittal 
cord  
atrophy 
Cervical 
cord  
signal 
change 
Cervical 
cord  
cross  
section 
Ant. 
Shift 
 of 
cord 
space behind 
dura 
contrast 
enhance
ment 
1 WF > WE Severe 1 1 2 3 3 Brisk Yes yes No No pear  yes yes  Yes 
2 WF > WE Severe 1 1 2 2 2 Brisk No yes yes Yes Triangular yes yes Yes 
3 WF > WE Severe 1 1 0 3 3 normal No yes yes No Triangular yes yes Yes 
4 WF > WE Severe 0 0 2 3 3 normal Yes yes yes No Triangular yes yes Yes 
5 WF > WE severe 0 0 2 3 3 normal No yes yes No Triangular yes yes Yes 
6 WF > WE severe 0 0 2 3 3 normal Yes yes No No Normal yes yes Yes 
7 WF > WE severe 0 0 3 3 3 Brisk No yes yes No Triangular no no No 
8 WF > WE severe 2 0 2 3 3 normal No yes yes Yes Triangular yes yes Yes 
9 WF > WE severe 2 0 2 3 3 normal Yes yes yes No pear  yes yes-upto T4  Yes 
10 WF > WE severe 0 0 2 3 3 Brisk No yes yes No Triangular yes yes Yes 
11 WF > WE severe 0 0 2 3 3 normal No yes yes No pear  yes yes Yes 
12 WF > WE severe 2 0 2 3 3 normal No yes yes Yes Triangular yes yes- upto T6 Yes 
13 WF > WE severe 0 0 0 3 3 normal No yes No No pear  No no No 
14 WF > WE severe 0 0 2 3 3 Brisk No yes yes No Triangular yes yes Yes 
15 WF > WE severe 0 0 2 3 3 normal No yes yes No Triangular yes yes Yes 
16 WF > WE severe 0 0 2 3 3 normal No yes yes No Triangular yes yes Yes 
17 WF > WE severe 1 1 2 3 3 Brisk Yes yes No No pear  yes yes  Yes 
18 WF > WE severe 1 1 2 2 2 Brisk No yes yes Yes Triangular yes yes Yes 
19 WF > WE severe 1 1 0 3 3 normal No yes yes No Triangular yes yes Yes 
20 WF > WE severe 0 0 2 3 3 normal Yes yes yes No Triangular yes yes Yes 
21 WF > WE severe 0 0 2 3 3 normal No yes yes No Triangular yes yes Yes 
22 WF > WE severe 0 0 2 3 3 normal Yes yes No No Normal yes yes Yes 
23 WF > WE severe 0 0 3 3 3 Brisk No yes yes No Triangular no no No 
24 WF > WE severe 2 0 2 3 3 normal No yes yes No Triangular yes yes Yes 
25 WF > WE severe 0 0 2 3 3 Brisk No yes yes No Triangular yes yes Yes 
26 WF > WE severe 0 0 2 3 3 normal No yes yes No pear  yes yes Yes 
27 WF > WE severe 2 0 2 3 3 normal No yes yes Yes Triangular yes yes Yes 
28 WF > WE severe 0 0 0 3 3 normal No yes No No pear  no no No 
29 WF > WE severe 0 0 2 3 3 Brisk No yes yes No Triangular yes yes Yes 
30 WF > WE severe 0 0 2 3 3 normal No yes yes No Triangular yes yes Yes 
31 WF > WE severe 0 0 2 3 3 normal No yes yes No Triangular yes yes Yes 
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sl.  
No. 
Rt M 
CMAP  
Rt U 
CMAP 
Rt M  
E 
f min  
Rt M 
 E  
f max 
Rt M  
E 
f mean 
Rt M  
E  
f disp 
Rt U  
E 
f min 
Rt U  
E  
f max  
Rt U  
E 
f mean 
Rt U 
E  
f disp 
Rt M 
F 
f min 
Rt M 
F 
f max 
Rt M 
F 
f mean 
Rt M 
F  
f disp 
Rt U  
F 
f min 
Rt U 
F 
f max 
Rt U 
F 
f mean 
 Rt U 
F 
f disp 
1 16.2 3.4 29.12 31.34 30.23 2.22 28.34 30.22 29.28 1.88 29.54 31.84 30.69 2.3 29.23 31.95 30.59 2.72 
2 10.2 5.8 28.16 30.49 29.33 2.33 28.82 30.93 29.88 2.11 30.24 34.2 32.22 3.96 30.38 34.22 32.3 3.84 
3 4.2 2.1 29.82 32.68 31.25 2.86 30.2 33.32 31.76 3.12 31.58 34.94 33.26 3.36 32.86 35.7 34.28 2.84 
4 NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS 
5 21.8 12.5 28.17 30.75 29.46 2.58 28.33 29.79 29.06 1.46 NS NS NS NS 30.42 33.29 31.86 2.87 
6 11.2 3.12 28.72 29.98 29.35 1.26 29.78 32.1 30.94 2.32 29.34 30.56 29.95 1.21 31.24 34.86 33.05 3.62 
7 5.1 2.4 28.79 32.21 30.5 3.42 29.73 32.84 31.26 3.11 31.16 35.12 33.14 3.96 32.25 35.84 34.05 3.59 
8 5.8 2.7 29.54 33.12 31.33 3.58 30.24 33.65 31.95 3.41 31.68 35.4 33.54 3.72 32.42 35.96 34.19 3.54 
9 12.1 2.86 29.34 32.1 30.72 2.76 28.82 32.94 30.88 4.12 29.56 32.9 31.23 3.56 29.57 34.34 31.95 4.77 
10 4.9 1.9 28.39 31.98 30.66 3.59 29.68 33.12 31.4 3.44 32.1 35.92 34.01 3.82 31.58 35.46 33.52 3.88 
11 10.8 2.3 26.04 27.5 26.7 1.46 28.66 31.24 29.95 2.58 25.42 27.08 26.25 1.66 NS NS NS NS 
12 12.2 6.2 29.1 31.38 30.24 2.28 29.14 31.04 30.1 1.9 31.24 34.68 32.96 3.44 31.12 34.26 32.69 3.14 
13 14.1 4.7 28.54 30.83 29.69 2.29 31.67 33.75 32.71 2.08 28.33 31.04 29.63 2.71 32.29 33.54 32.92 1.29 
14 5.6 1.5 29.24 30.82 30.04 1.58 30.38 33.46 31.92 3.08 31.34 34.96 33.15 3.62 31.96 36.24 34.1 4.28 
15 25.3 16.9 26.46 30.84 28.65 4.38 27.92 31.88 29.9 3.96 27.71 31.88 29.79 4.17 29.17 33.96 31.56 4.79 
16 11 7.5 28.26 31.88 30.08 3.62 29.66 32.69 31.18 3.03 29.86 34.92 32.39 5.06 31.64 35.28 33.46 3.64 
17 16.2 3.4 29.12 31.34 30.23 2.22 28.34 30.22 29.28 1.88 29.54 31.84 30.69 2.3 29.23 31.95 30.59 2.72 
18 10.2 5.8 28.16 30.49 29.33 2.33 28.82 30.93 29.88 2.11 30.24 34.2 32.22 3.96 30.38 34.22 32.3 3.84 
19 4.2 2.1 29.82 32.68 31.25 2.86 30.2 33.32 31.76 3.12 31.58 34.94 33.26 3.36 32.86 35.7 34.28 2.84 
20 NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS 
21 21.8 12.5 28.17 30.75 29.46 2.58 28.33 29.79 29.06 1.46 NS NS NS NS 30.42 33.29 31.86 2.87 
22 11.2 3.12 28.72 29.98 29.35 1.26 29.78 32.1 30.94 2.32 29.34 30.56 29.95 1.21 31.24 34.86 33.05 3.62 
23 5.1 2.4 28.79 32.21 30.5 3.42 29.73 32.84 31.26 3.11 31.16 35.12 33.14 3.96 32.25 35.84 34.05 3.59 
24 5.8 2.7 29.54 33.12 31.33 3.58 30.24 33.65 31.95 3.41 31.68 35.4 33.54 3.72 32.42 35.96 34.19 3.54 
25 4.9 1.9 28.39 31.98 30.66 3.59 29.68 33.12 31.4 3.44 32.1 35.92 34.01 3.82 31.58 35.46 33.52 3.88 
26 10.8 2.3 26.04 27.5 26.7 1.46 28.66 31.24 29.95 2.58 25.42 27.08 26.25 1.66 NS NS NS NS 
27 12.2 6.2 29.1 31.38 30.24 2.28 29.14 31.04 30.1 1.9 31.24 34.68 32.96 3.44 31.12 34.26 32.69 3.14 
28 14.1 4.7 28.54 30.83 29.69 2.29 31.67 33.75 32.71 2.08 28.33 31.04 29.63 2.71 32.29 33.54 32.92 1.29 
29 5.6 1.5 29.24 30.82 30.04 1.58 30.38 33.46 31.92 3.08 31.34 34.96 33.15 3.62 31.96 36.24 34.1 4.28 
30 25.3 16.9 26.46 30.84 28.65 4.38 27.92 31.88 29.9 3.96 27.71 31.88 29.79 4.17 29.17 33.96 31.56 4.79 
31 11 7.5 28.26 31.88 30.08 3.62 29.66 32.69 31.18 3.03 29.86 34.92 32.39 5.06 31.64 35.28 33.46 3.64 
 
 
  
 
MASTER CHART – PATIENTS WITH HIRAYAMA DISEASE – PART 5 
 
 
 
sl.  
No. 
Lt M 
CMAP  
Lt U 
CMAP 
Lt M  
E 
f min  
Lt M 
 E  
f max 
Lt M  
E 
f mean 
Lt M  
E  
f disp 
Lt U  
E 
f min 
Lt U  
E  
f max  
Lt U  
E 
f mean 
Lt U 
E  
f disp 
Lt M 
F 
f min 
Lt M 
F 
f max 
Lt M 
F 
f mean 
Lt M 
F  
f disp 
Lt U  
F 
f min 
Lt U 
F 
f max 
Lt U 
F 
f mean 
Lt U 
F 
f disp 
1 14.2 4.5 29.84 32.88 31.36 3.04 30.24 34.46 32.35 4.22 31.21 33.25 32.23 2.04 31.11 35.68 33.95 4.57 
2 10.2 2.8 27.49 30.94 29.22 3.45 29.4 31.29 30.35 1.89 29.48 32.82 31.15 3.34 30.96 34.42 32.69 3.46 
3 6.2 2.5 29.59 32.63 31.11 3.04 30.28 32.93 31.6 2.65 31.2 35.38 33.29 4.18 32.34 35.86 34.1 3.62 
4 7.5 NS 31.43 36.42 33.93 4.99 NS NS NS NS NS NS NS NS NS NS NS NS 
5 NS 1.8 NS NS NS NS 32.92 39.17 36.04 6.25 NS NS NS NS NS NS NS NS 
6 14.2 11.8 26.71 28.2 27.46 1.49 26.58 28.47 27.53 1.89 27.49 28.95 28.22 1.46 29.32 30.84 30.08 1.52 
7 8.2 3.6 28.3 32.14 30.22 3.84 29.3 32.5 30.9 3.2 29.8 34.1 31.95 4.3 31.82 36.4 34.11 4.58 
8 6.9 2.8 29.49 32.84 31.66 3.35 30.28 33.42 31.85 3.14 30.8 34.76 32.78 3.96 32.4 36.92 34.66 2.52 
9 15.6 13 27.12 28.98 28.05 1.86 27.88 29.87 28.88 1.99 27.24 28.56 27.9 1.32 28.94 31.1 28.52 2.16 
10 7.9 3.5 28.98 32.26 30.62 3.28 29.51 32.85 31.18 3.34 31.28 35.32 33.3 4.04 31.6 35.12 33.36 3.52 
11 16.4 12.7 25.21 26.42 25.83 1.12 27.29 30.21 28.75 2.92 24 26.83 25.42 2.83 26.67 28.33 27.5 1.66 
12 9.4 3.6 27.94 30.78 29.36 2.84 30.24 33.21 31.73 2.97 29.96 33.29 31.63 3.33 31.82 36.24 34.03 4.42 
13 12.2 9.5 28.96 31.46 30.21 2.5 30.83 34.38 32.61 3.55 26.46 29.38 27.92 2.92 NS NS NS NS 
14 5.2 1.2 29.2 31.92 30.56 2.71 30.38 33.24 31.81 2.86 30.62 35.24 32.93 4.62 32.28 37.34 34.81 5.06 
15 11.3 9.1 26.88 31.67 29.27 4.79 27.71 31.04 29.38 3.33 NS NS NS NS NS NS NS NS 
16 6.9 4.2 28.46 30.98 29.72 2.52 29.74 31.93 30.84 2.19 30.18 33.48 31.83 3.3 31.26 34.28 32.77 3.02 
17 14.2 4.5 29.84 32.88 31.36 3.04 30.24 34.46 32.35 4.22 31.21 33.25 2.04 32.23 31.11 35.68 33.95 4.57 
18 10.2 2.8 27.49 30.94 29.22 3.45 29.4 31.29 30.35 1.89 29.48 32.82 31.15 3.34 30.96 34.42 32.69 3.46 
19 6.2 2.5 29.59 32.63 31.11 3.04 30.28 32.93 31.6 2.65 31.2 35.38 33.29 4.18 32.34 35.86 34.1 3.62 
20 7.5 NS 31.43 36.42 33.93 4.99 NS NS NS NS NS NS NS NS NS NS NS NS 
21 NS 1.8 NS NS NS NS 32.92 39.17 36.04 6.25 NS NS NS NS NS NS NS NS 
22 14.2 11.8 26.71 28.2 27.46 1.49 26.58 28.47 27.53 1.89 27.49 28.95 28.22 1.46 29.32 30.84 30.08 1.52 
23 8.2 3.6 28.3 32.14 30.22 3.84 29.3 32.5 30.9 3.2 29.8 34.1 31.95 4.3 31.82 36.4 34.11 4.58 
24 6.9 2.8 29.49 32.84 31.66 3.35 30.28 33.42 31.85 3.14 30.8 34.76 32.78 3.96 32.4 36.92 34.66 2.52 
25 7.9 3.5 28.98 32.26 30.62 3.28 29.51 32.85 31.18 3.34 31.28 35.32 33.3 4.04 31.6 35.12 33.36 3.52 
26 16.4 12.7 25.21 26.42 25.83 1.12 27.29 30.21 28.75 2.92 24 26.83 25.42 2.83 26.67 28.33 27.5 1.66 
27 9.4 3.6 27.94 30.78 29.36 2.84 30.24 33.21 31.73 2.97 29.96 33.29 31.63 3.33 31.82 36.24 34.03 4.42 
28 12.2 9.5 28.96 31.46 30.21 2.5 30.83 34.38 32.61 3.55 26.46 29.38 27.92 2.92 NA NS NS NS 
29 5.2 1.2 29.2 31.92 30.56 2.71 30.38 33.24 31.81 2.86 30.62 35.24 32.93 4.62 32.28 37.34 34.81 5.06 
30 11.3 9.1 26.88 31.67 29.27 4.79 27.71 31.04 29.38 3.33 NS NS NS NS NS NS NS NS 
31 6.9 4.2 28.46 30.98 29.72 2.52 29.74 31.93 30.84 2.19 30.18 33.48 31.83 3.3 31.26 34.28 32.77 3.02 
  
 
NERVE CONDUCTION VALUES IN CONTROL SUBJECTS 
 
 
Abbreviations and Codes 
 
1) M = median nerve 
2) U = Ulnar nerve 
3) CMAP – compound muscle action potential 
4) E = value recorded with neck in extension / neutral postion 
5) F = value recorded with neck in flexion 
6) f = f wave latency 
7) disp =Chronodispersion 
8) NS  = not stimulatable 
9) DTR = deep tendon reflex 
10)  Min = minimum latency 
11) Max = maximum latency 
12) WF = wrist flexor 
13) WE = Wrist extensor 
 
 
sl.  
No. 
Media 
CMAP  
Ulnar 
CMAP 
M  E 
f min  
M   E  
f max 
M   E 
f mean 
M   E  
f disp 
U   E 
f min 
U  E  
f max  
U   E 
f mean 
U   E  
f disp 
M   F 
f min 
M   F 
f max 
M   F 
f  mean 
M   F  
f disp 
U   F 
f min 
U    F 
f max 
U    F 
f mean 
U   F 
f disp 
1 14.1 11.2 26.67 28.33 27.5 1.66 27.71 29.58 28.65 1.87 28.33 30.21 29.27 1.88 27.7 29.58 28.5 1.88 
2 14.3 8.3 25 28.96 26.98 3.96 24.38 27.5 25.94 3.12 23.96 28.13 26.04 4.17 25 28.33 26.67 3.33 
3 25.5 12.4 23.96 27.29 25.63 3.33 23.13 26.46 24.79 3.33 24.17 26.04 25.1 1.87 23.96 25.42 21.25 1.46 
4 14.4 11.4 23.71 26.71 25.21 3 22.5 25 23.75 2.5 23.54 26.46 25 2.92 22.92 26.04 24.48 3.12 
5 13.6 13.6 25 27.29 26.15 2.29 22.61 25.32 23.75 2.71 25 26.25 25.6 1.25 22.71 24.17 23.44 1.46 
6 14.9 12.4 24.94 27.93 26.44 2.99 24.69 28.49 26.59 3.8 25.78 29.24 27.51 3.46 25.82 29.12 27.47 3.3 
7 15.2 11.2 23.24 25.42 24.33 2.18 24.84 27.62 26.23 2.78 25.12 26.98 26.1 1.86 25.6 28.98 27.29 3.38 
8 20.4 14.2 24.66 27.25 25.96 2.59 23.76 25.37 24.57 1.58 26.2 28.52 27.36 2.32 25.21 28.59 26.9 3.4 
9 18.2 13.1 25.29 27.28 26.29 1.99 25.38 27.24 26.31 1.86 25.99 28.21 27.1 2.22 26.21 28.22 27.22 2 
10 15.8 11.2 26.2 28.4 27.3 2.2 25.4 27.8 26.6 2.4 27.6 29.88 28.74 2.28 26.64 27.48 27.1 0.84 
  
 
 
 
 
 
 
 
 
 
 
PROFORMA 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
PROFORMA 
 
Name:       Neuro no. : 
 
Age:        Gender: 
 
Occupation:      Handedness:  
 
Disease duration (months):    Age of onset (years): 
 
 
 
Iimb involvement:              Distal – Y/N     Proximal – Y/N 
     
Unilateral:   Y/N  Right / Left 
 
Bilateral:           Y/N       Right > Left / Left > Right / Right = Left 
 
Weakness:   Y/ N  Wasting: Y/N 
 
Tremulousness: Y/N 
 
Fasciculation:   Y/N 
 
Cold paresis:   Y/N  
 
 
 
Muscle involvement 
 
Deltoid:   Y/N   
 
Biceps:   Y/N 
 
Brachioradialis:  Y/N 
 
Triceps:   Y/N 
 
FDS:   Y/N 
  
 
 
FDP:   Y/N 
 
Wrist extensor:  Y/N 
 
Wrist Flexor:  Y/N    
 
Wrist  : Extensor > Flexor  Flexor > Extensor  
 
Intrinsic hand muscle:  Y/N 
 
 
Myotome involved 
 
C5:  Y/N 
 
C6:  Y/N 
 
C7:  Y/N 
 
C8:  Y/N 
 
T1:  Y/N 
 
Deep tendon reflexes:    Normal / Absent / Sluggish / Brisk 
 
Sensory:  Y/N 
 
 
 
 
Nerve conduction study 
 
 
Median nerve 
 Right        Left 
Neck position Extension Flexion Extension Flexion 
CMAP   
F minimum     
F mximum     
F mean latency     
Chronodispersion      
SNAP   
  
 
Ulnar nerve 
 Right Left 
Neck position Extension Flexion Extension Flexion 
CMAP   
F minimum     
F mximum     
F mean latency     
Chronodispersion      
SNAP   
 
 
 
MRI findings 
 
Straightening of C3 – C6 spine:      Y/N  
 
Lower cervical cord atrophy  
 - Sagittal view in neck extension-    Y/N 
 - Axial view - Normal elliptical / Pear shaped / Triangular 
  
Anterior shift of cord on neck flexion:         Y/N 
 
Anterior buckling of posterior dural sac:         Y/N  
 
 
Cresentic space posterior to dura in neck flexion:   Y/N 
 
Flow voids in cresentic space in neck flexion:   Y/N 
 
Contrast enhancement of flow voids:     Y/N 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
ANNEXURES 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
ந ோயோளிகளின்  தகவல் குறியீடு 
 
1) ஹிறாயாமா ந ாய் ப ாதுவாக 15  இல் இருந்து  25 
வயது  வரை   உள்ள  ஆண்கரள  மிகவும்  அதிகமாக  
 ாதிக்கும்  
2) ஹிறாயாமா  ந ாய் என் து  முதுகு தண்டுவட ந ாய். 
 இந்த  ந ாய் ப ாதுவாக  ரக தரைகரள  ாதிக்கும். 
3) இந்த ந ாயில்  ரக  ிடிப்பு தன்ரம  குரறந்துவிடும்,   
ரக  டுக்கம்  இருக்கும்,  தரைகள்  சுருங்கி   வலு 
 இழந்துவிடும். 
4) இந்த  ந ாயில் வலிநயா அல்லது உணர்ச்ைியற்ற 
 தன்ரமநயா இருக்காது. 
5) இந்த  ந ாயின்  காைணங்கரள  கண்டறியும்,  ைிறந்த 
ைிகிச்ரைகள்  குறித்தும்  உலகளாவிய  ஆைாய்ச்ைிகள் 
நமற்பகாள்ளப் ட்டு  வருகிறது.    
 
 
 
 
 
 
 
  
 
சுய  ஒப்புதல் படிவம் 
 
 ங்கு ப று வரின் ப யர் : 
 ாலினம் :  ஆண் _______ / ப ண்  ______ 
வயது : 
முகவரி : 
 
பதாரலந ைி எண் : 
 .  
1) எனக்கு ஹிறாயாமா எனப் டும் முதுகு தண்டுவட ந ாய் 
இருக்கிறது என்று  பதரிவிக்க ட்டுள்ளது. 
2) இந்த ந ாய் குறித்து  ஆய்வில் (Study of clinical spectrum of 
Hirayama disease in a referral hospital  in south India)  ங்குபகாள்ள 
 ான் முழுமனநதாடுஒப்புக் பகாள்கிநறன் .  
3)  இந்த  மருத்துவ  ஆய்வின் விவைங்கள் எனக்கு விளக்கப் ட்டது . 
என்னுரடய  ைந்நதகங்கரள நகட்கவும் அதற்கான தகுந்த 
விளக்கங்கரள ப றவும் வாய்ப் ளிக்கப் ட்டது . 
4) இந்த ஆய்விற்கு நதரவ டும்  ரிநைாதரனகரள (எம் .ஆர் .ஐ 
ஸ்நகன்,  ைம்பு  மின்  ரிநைாதரன)  பைய்து பகாள்ள  ான் முழு 
மனதுடன் ைம்மதிக்கிநறன். 
5) இந்த ஆய்வின் முடிவுகள் மற்ற ந ாயாளிகளுக்கு ைிகிச்ரை 
அளிக்கவும்  ிற்காலத்தில் உதவியாக இருக்கும் என் தும் 
எனக்கு பதரிவிக்கப் ட்டது. 
6) இந்த ஆய்வின் முடிவுகரள அறிவியல் ைார்ந்த மருத்துவ 
இதழ்கள்  ிைசுரிக்கவும்  ான் ைம்மதிக்கிநறன். 
 
 ங்நகற் வரின் ரகபயாப் ம் /  
கட்ரடவிைல் நைரக                            : 
 
ஆய்வாளரின் ரகபயாப் ம்               : 
 
இடம் :  
நததி :               
